Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Luminex Corporation LMNX

Healthcare
Luminex Corp develops, manufactures, and sells proprietary biological testing technologies and products to testing laboratories. It primarily serves the life sciences industries by selling products used by laboratory professionals and clinical laboratories in performing diagnostics, drug research and discovery, and clinical tests on patients. Luminex's market segments mainly include Infectious disease, Personalized medicine, and Human genetics. It offers various solutions in diverse markets, inc


NDAQ:LMNX - Post by User

Luminex Corporation > Blew through $30 USD
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1195)
•••
Comment by Moemoney42on Mar 27, 2020 2:14pm
63 Views
Post# 30853855

RE:RE:RE:RE:RE:RE:Blew through $30 USD

RE:RE:RE:RE:RE:RE:Blew through $30 USDWow... this headline from last year rings true again today.. blew through $30 in a flash today with the report that LMNX has received FDA approval for emergency use of its NxTAG CoV Extended panel Assay for COVID-19   ;-)

Moe $$
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities